Stay updated on Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now communicates a funding-related operating-status notice and that the NIH Clinical Center is open, along with a version upgrade to v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check27 days agoChange DetectedAdded a new version label (v3.1.0) and removed several MedlinePlus drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older version note (v3.0.2).SummaryDifference0.5%

- Check42 days agoChange DetectedUpdated Revision from v3.0.1 to v3.0.2; removed the Back to Top link. This is a minor update with no changes to core content, pricing, stock, or dates.SummaryDifference0.2%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has been updated to include specific facility names and locations in South Korea, along with new content related to drug safety and counterfeit drugs. The previous version's references to certain locations and diseases have been removed.SummaryDifference4%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy in Atopic Dermatitis Clinical Trial page.